Clinical Trials Directory

Trials / Completed

CompletedNCT00001323

Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia

Neuropsychiatric Evaluation of Normal Subjects and Psychiatric and Neurologic Contrast Groups

Status
Completed
Phase
Study type
Observational
Enrollment
810 (planned)
Sponsor
National Institute of Mental Health (NIMH) · NIH
Sex
All
Age
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the cognitive processes of participants with schizophrenia, participants with nervous system and mental disorders, and healthy volunteers. Participants in this study will undergo cognitive tests of attention, memory, attention. Participants with attention deficit hyperactivity disorder (ADHD), traumatic brain injury (TBI), bipolar disorder, and Alzheimer's disease (AD) will be compared with participants with schizophrenia. A group of healthy adults and children will undergo cognitive tests to further delineate the degree of impairment in schizophrenia and neurological disorder participants.

Detailed description

In this study, we propose to administer cognitive tests to schizophrenic patients and to neurologic patients who will serve as contrast groups for neuropsychological studies of patients with schizophrenia. These include studies of Alzheimers disease to dissociate size and organization of lexicon and ADHD to understand error patterns on CPT-type tests of attention and vigilance. However, the majority of studies will examine schizophrenia in relation to normal controls. In addition, we propose to obtain test results from a local sample of normal subjects of varying ages and educational backgrounds to further delineate degree of impairment in these clinical groups. As well as assessing adults we wish to assess normal children. In particular, we wish to identify in children the size of their lexicon and their degree of semantic organization within their lexicon.

Conditions

Timeline

Start date
1992-08-01
Completion
2005-08-01
First posted
1999-11-04
Last updated
2008-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00001323. Inclusion in this directory is not an endorsement.